Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation and Delivery of Lenacapavir for PrEP in a Community Pharmacy Setting

NCT07210125 is registered in ClinicalTrials.gov with Kelley-Ross & Associates, Inc. as lead sponsor.

NCT NCT07210125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07210125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation and Delivery of Lenacapavir for PrEP in a Community Pharmacy Setting
Lead sponsor
Kelley-Ross & Associates, Inc.
Phase
Phase 4
Overall status
Active, not recruiting
Start date
September 16, 2025
Completion date
June 30, 2027
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv